
NewLeaf Symbiotics
Science-based company doing cutting-edge research and product development, using a naturally occurring family of beneficial plant bacteria.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor investor investor investor investor investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor investor investor | €0.0 Valuation: €0.0 | round | |
N/A | €0.0 | round | |
* | $45.0m | Series D | |
Total Funding | 000k |
Related Content
NewLeaf Symbiotics is an agricultural biotechnology company that develops and commercializes products based on a family of beneficial bacteria known as Pink Pigmented Facultative Methylotrophs (PPFMs). The company's core business revolves around harnessing these naturally occurring microbes to create sustainable agricultural solutions that can enhance crop health and yield.
NewLeaf Symbiotics serves the agricultural market, with its products being applied to a variety of crops. The company's business model is centered on the research, development, and subsequent sale of these proprietary microbial products. It generates revenue through the commercialization of its PPFM-based technologies, which are offered as seed treatments or in-furrow applications to improve plant performance.
Keywords: agricultural biotechnology, microbial products, sustainable agriculture, crop health, PPFMs, agritech, crop yield, seed treatments, agricultural solutions, beneficial bacteria
Tech stack
Investments by NewLeaf Symbiotics
Edit